cardiovascular system
• in isoproterenol-treated mice
|
• isoproterenol-treated mice exhibit disorganized shifts of the leading pacemaker and competing multiple pacemakers compared with similarly treated wild-type mice
• acetylcholine-treated mice exhibit reduced sensitivity of pacemaker function compared with similarly treated wild-type mice
|
homeostasis/metabolism
• isoproterenol-treated mice exhibit increased heart rate variability, a larger beat-to-beat variability, disorganized shifts of the leading pacemaker, and competing multiple pacemakers compared with similarly treated wild-type mice
• acetylcholine-treated mice exhibit reduced sensitivity of pacemaker function compared with similarly treated wild-type mice
|
adipose tissue
• mouse embryonic fibroblasts exhibit increased adipogenesis with both increased in adipocyte numbers and enlarged lipid droplets compared with wild-type cells.
|
• decreased basal adipocyte glucose uptake
• however, insulin-stimulated uptake is normal
|
cellular
• mouse embryonic fibroblasts exhibit increased adipogenesis with both increased in adipocyte numbers and enlarged lipid droplets compared with wild-type cells.
|
• decreased basal adipocyte glucose uptake
• however, insulin-stimulated uptake is normal
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
sinoatrial node disease | DOID:0050824 | J:163867 |